Global Statistics

All countries
240,231,299
Confirmed
Updated on October 14, 2021 7:22 pm
All countries
215,802,873
Recovered
Updated on October 14, 2021 7:22 pm
All countries
4,893,546
Deaths
Updated on October 14, 2021 7:22 pm

Global Statistics

All countries
240,231,299
Confirmed
Updated on October 14, 2021 7:22 pm
All countries
215,802,873
Recovered
Updated on October 14, 2021 7:22 pm
All countries
4,893,546
Deaths
Updated on October 14, 2021 7:22 pm

Bremelanotide for Low Sex Drive in Women: Drug Warnings


Generic drug: bremelanotide

Brand name: Vyleesi

What is Vyleesi (bremelanotide), and how does it work?

Vyleesi (bremelanotide) injection is indicated for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD), as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is NOT due to:

  • A co-existing medical or psychiatric condition,
  • Problems with the relationship, or
  • The effects of a medication or drug substance.

Acquired HSDD refers to HSDD that develops in a patient who previously had no problems with sexual desire. Generalized HSDD refers to HSDD that occurs regardless of the type of stimulation, situation or partner.

Limitations Of Use

  • Vyleesi is not indicated for the treatment of HSDD in postmenopausal women or in men.
  • Vyleesi is not indicated to enhance sexual performance.

COVID Antiviral Pill Approval

  • Are Diet Drinks Any Better?
  • Diabetes Ups Alzheimer’s Risk
  • Key Protein in TBI Patients
  • Breastfeeding Helps Postpartum Depression
  • XML More Health News »
  • Trending on MedicineNet

    Is Vyleesi safe to use while pregnant or breastfeeding?

    • The few pregnancies in women exposed to Vyleesi in clinical trials are insufficient for determining whether there is a drug-associated risk for major birth defects, miscarriage or adverse maternal or fetal outcomes.
    • There is no information on the presence of bremelanotide or its metabolites in human milk, the effects on the breastfed infant, or the effects on milk production.
    • The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for
      Vyleesi and any potential adverse effects on the breastfed child from
      Vyleesi or from the underlying maternal condition.

    Hot Topics

    Related Articles